Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY900014 Titration Scheme in Type 1 Diabetes
NCT04585776Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2020
- Primary completion
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of insulin lispro in type 1 diabetes mellitus (T1D), sponsored by Eli Lilly and Company. Started Oct 2020; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04585776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04585776.